Peptide-MHC Interaction: A Rational Approach to Vaccine Design

References

• Shimonkevitz R., Kappler J., Marrack P., Grey H. M. Antigen recognition by H-2 restricted T cells. I. Cell-free antigen processing. J. Exp. Med. 1983; 158: 303–316
   PubMedGoogle Scholar
• Brown J. H., Jardetzky T., Saper M. A., Samroui B., Bjorkman P. J., Wiley D. C. A hypothetical model of the foreign antigen binding site of Class II histocompatibility molecules. Nature 1988; 332: 845–850
   PubMed Web of Science ®Google Scholar
• Schwartz R. H. The role of gene products of the major histocompatibility complex in T cell activation and cellular interactions. Fundamental Immunology, W. E. Paul. Raven, New York 1984; 379–438
   Google Scholar
• Babbit B. P., Allen P. M., Matsueda G., Haber E., Unanue E. Binding of immunogenic peptides in la histocompatibility molecules. Nature 1985; 317: 359–361
   PubMed Web of Science ®Google Scholar
• Buus S., Sette A., Colon S. M., Miles C., Grey H. M. The relation between major histocompatibility complex (MHC) restriction and the capacity of la to bind immunogenic peptides. Science 1985; 235: 1353–1358
   Google Scholar
• Buus S., Sette A., Colon S. M., Jenis D. M., Grey H. M. Isolation and characterization of antigen-la complexes involved in T cell recognition. Cell 1986; 47: 1071–1077
   PubMed Web of Science ®Google Scholar
• Rothbard J. B., Taylor W. R. A sequence pattern common to T cell epitopes. EMBO J. 1988; 7: 93–100
   PubMed Web of Science ®Google Scholar
• Sinigaglia F., Guttinger M., Gillessen D., Doran D. M., Takacs B., Matile H., Trzeciak A., Pink J. R. L. Epitopes recognized by human T lymphocytes on malaria circumsporozoite protein. Eur. J. Immunol. 1988; 18: 633–636
   PubMed Web of Science ®Google Scholar
• Kilgus J., Romagnoli P., Guttinger M., Adorini L., Sinigaglia F. Vaccine T-cell epitope selection by a peptide competition assay. Proc. Natl. Acad. Sci. USA 1989; 86: 1629–1633
   Google Scholar
• Sinigaglia F., Guttinger M., Kilgus J., Doran D. M., Matile H., Etlinger H., Trzeciak A., Gillessen D., Pink J. R. L. A malaria T-cell epitope recognized in association with most mouse and human MHC molecules. Nature 1988; 336: 778–780
   PubMed Web of Science ®Google Scholar
• Pink J. R. L., Sinigaglia F. Characterizing T-cell epitopes in vaccine candidates. Immunol. Today 1989; 10: 408–409
   Google Scholar
• Sinigaglia F., Matile H., Guttinger M., Pink J. R. L. An invariant, “universal” T cell epitope in the P. falciparum circumsporozoite protein. Bull. WHO, (in press)
   Google Scholar
• Sinigaglia F., Kilgus J., Romagnoli R, Guttinger M., Pink J. R. L. Peptide binding to MHC class II molecules: applications to vaccine design. Progress in Immunology, F. Melchers, et al. Springer-Verlag, Berlin, Heidelberg, New York 1989; VII: 1137–1143
   Google Scholar
• Berkower I., Buckenmeyer G. K., Berzofsky J. A. Molecular mapping of a histocompatibility-restricted immunodominant T cell epitope with synthetic and natural peptides: Implication for the T cell antigenic structure. J. Immunol. 1986; 136: 2498–2503
   Google Scholar
• Rothbard J. B., Lechler R. I., Howland K., Bal V., Eckles D. D., Sekaly R., Long E. O., Taylor W. R., Lamb J. R. Structural model of HLA-DRI restricted T cell antigen recognition. Cell 1988; 52: 515–523
   PubMed Web of Science ®Google Scholar
• Sette A., Lamont A., Buus S., Colon S. M., Miles C., Grey H. M. Effect of conformational propensity of peptide antigens in their interaction with MHC class II molecules. Failure to document the importance of regular secondary structures. J. Immunol. 1989; 143: 1268–1273
   PubMedGoogle Scholar
• Heber-Katz E., Hollosi M., Dietzschold B., Hudecz E., Fathman G. D. The T cell response to the glycoprotein D of the herpes simplex virus: the significance of antigen conformation. J. Immunol. 1985; 135: 1385–1390
   Google Scholar
• Fox B. S., Chen C., Fraga E., French C. A., Singh B., Schwartz R. H. Functionally distinct agretopic and epitopic sites. Analysis of the dominant T cell determinant of moth and pigeon cytochromes c with the use of synthetic peptide antigens. J. Immunol. 1987; 139: 1578–1588
   PubMed Web of Science ®Google Scholar
• Ogasawara K., Maloy W. L., Beverly B., Schwartz R. H. Functional analysis of the antigenic structure of a minor T cell determinant from pigeon cytochrome C. Evidence against an α-helical conformation. J. Immunol. 1989; 142: 1448–1456
   Google Scholar
• Bhayani H., Paterson Y. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations. J Exp. Med. 1989; 170: 1609–1625
   Google Scholar
• Nussenzweig V., Nussenzweig R. Rationale for the development of an engineered sporozoite malaria vaccine. Adv. Immunol. 1989; 45: 283–334
   PubMed Web of Science ®Google Scholar
• Tam J. P. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. USA 1988; 85: 5409–5413
   PubMed Web of Science ®Google Scholar
• Tam J. P., Clavijo P., Lu Y. A., Nussenzweig V., Nussenzweig R., Zavala F. Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J. Exp. Med. 1990; 171: 299–306
   PubMed Web of Science ®Google Scholar
• Good M. F., Pombo D., Quakyi I. A., Riley E. M., Houghten R. A., Menon A., Alling D. W., Berzofsky J. A., Miller L. H. Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: Immunodominant T-cell domains map to the polymorphic regions of the molecule. Proc. Natl. Acad. Sci. USA 1988; 85: 1199–1203
   PubMed Web of Science ®Google Scholar
• Adorini L., Appella E., Doria G., Nagy Z. A. Mechanisms influencing the immunodominance of T cell determinants. J. Exp. Med. 1988; 168: 2091–2104
   PubMedGoogle Scholar
• Panina-Bordignon P., Tan A., Termijtelen A., Demotz S., Corradin G., Lanzavecchia A. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 1989; 19: 2237–2241
   PubMed Web of Science ®Google Scholar
• Rothbard J. B., Hill C. M., Hickling J., Busch R. Progress in Immunology, F. Melchers, et al. Springer, Berlin-Heidelberg, New York, VII: 1115
   Google Scholar
• Deres K., Schild H., Wiesmuller K. H., Gunther J., Rammensee H. G. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 1989; 342: 561–564
   PubMed Web of Science ®Google Scholar